Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C3H7N |
| Molecular Weight | 57.0944 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NCC=C
InChI
InChIKey=VVJKKWFAADXIJK-UHFFFAOYSA-N
InChI=1S/C3H7N/c1-2-3-4/h2H,1,3-4H2
| Molecular Formula | C3H7N |
| Molecular Weight | 57.0944 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Co-culture of hepatocytes and fibroblasts by micropatterned immobilization of beta-galactose derivatives. | 2004-08 |
|
| Regulation of alpha7-integrin expression in vascular smooth muscle by injury-induced atherosclerosis. | 2004-07 |
|
| Biomimetic glucose recognition using molecularly imprinted polymer hydrogels. | 2004-05 |
|
| Modulation of cyclin dependent kinase inhibitor proteins and ERK1/2 activity in allylamine-injured vascular smooth muscle cells. | 2004-04-15 |
|
| Fabrication of polyelectrolyte multilayer films comprising nanoblended layers. | 2004-03-03 |
|
| Hypolipidemic therapy and cholesterol absorption. | 2004-03 |
|
| Polyelectrolyte-modified short microchannel for cation separation. | 2004-03 |
|
| Studies of interaction between poly(allylamine hydrochloride) and double helix DNA by spectral methods. | 2004-02-15 |
|
| Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells. | 2004-01-01 |
|
| Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues. | 2004-01 |
|
| Quantitative study of HIV-1 Tat peptide and TAR RNA interaction inhibited by poly(allylamine hydrochloride). | 2003-12-12 |
|
| Enantioselective alpha-silyl amino acid synthesis by reverse-aza-Brook rearrangement. | 2003-11-27 |
|
| Organomercury bioconjugate synthesis and characterization by matrix-assisted laser desorption ionization mass spectrometry. | 2003-11-20 |
|
| Overview of pharmacologic therapy for the treatment of dyslipidemia. | 2003-11-14 |
|
| The efficacy and safety of terbinafine in children. | 2003-11 |
|
| 3-D surface charges modulate protrusive and contractile contacts of chondrosarcoma cells. | 2003-11 |
|
| Inhibition of bovine plasma amine oxidase by 1,4-diamino-2-butenes and -2-butynes. | 2003-10-15 |
|
| Construction of a molecular imprinting catalyst using target analogue template and its application for an amperometric fructosylamine sensor. | 2003-10-15 |
|
| Surface properties of and cell adhesion onto allylamine-plasma-coated polyethylenterephtalat membranes. | 2003-10 |
|
| [Treatment of interdigital tinea pedis]. | 2003-09-05 |
|
| Synthesis and structure-activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors. | 2003-07-17 |
|
| Effect of the polycation nature on the structure of layer-by-layer electrostatically self-assembled multilayers of polyphenol oxidase. | 2003-07-15 |
|
| The use of oral antifungal agents to treat onychomycosis. | 2003-07 |
|
| Acute generalized exanthematous pustulosis induced by terbinafine. | 2003-06-14 |
|
| Asymmetric synthesis of alpha-amino allyl, benzyl, and propargyl silanes by metalation and rearrangement. | 2003-05-29 |
|
| Reduction of a 1-aza-1,3-diene to a 1-azabut-2-ene-1,4-diyl dianion: an unusual reaction course. | 2003-05-25 |
|
| Fabrication and photoelectric response of poly(allylamine hydrochloride)/PM thin films by layer-by-layer deposition technique. | 2003-05-23 |
|
| Highly potent propargylamine and allylamine inhibitors of bovine plasma amine oxidase. | 2003-05-16 |
|
| Colesevelam HCl: a non-systemic lipid-altering drug. | 2003-05 |
|
| Iodine atom transfer [3 + 2] cycloaddition reaction with electron-rich alkenes using N-tosyliodoaziridine derivatives as novel azahomoallyl radical precursors. | 2003-04-18 |
|
| N-silyl-tethered radical cyclizations: a new synthesis of gamma-amino alcohols. | 2003-04-17 |
|
| alpha-Keto amides as precursors to heterocycles--generation and cycloaddition reactions of piperazin-5-one nitrones. | 2003-04-07 |
|
| In vitro antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers. | 2003-04-03 |
|
| Identifying effective and/or safe doses by stepwise confidence intervals for ratios. | 2003-03-30 |
|
| Beyond statins. New drugs can work with, or in place of, cholesterol-lowering statins. | 2003-02 |
|
| Fullerene-coated beads as reusable catalysts. | 2003-01-24 |
|
| Rational design of cytophilic and cytophobic polyelectrolyte multilayer thin films. | 2003-01-14 |
|
| Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents. | 2003-01 |
|
| Simple preparation of biotinylated RNA by transcription via an unnatural base pair. | 2003 |
|
| Ultrasensitive probing of the protein resistance of PEG surfaces by secondary ion mass spectrometry. | 2002-12 |
|
| Development of a new Lewis acid-catalyzed [3,3]-sigmatropic rearrangement: the allenoate-Claisen rearrangement. | 2002-11-20 |
|
| Nanoencapsulated microcrystalline particles for superamplified biochemical assays. | 2002-11-01 |
|
| Rifampicin and treatment of cholestatic pruritus. | 2002-11 |
|
| Rapid access to tetracyclic ring system of lennoxamine type natural product by combined use of a novel three-component reaction and Pummerer cyclization. | 2002-10-21 |
|
| Ring-closing metathesis of chiral allylamines. Enantioselective synthesis of (2S,3R,4S)-3,4-dihydroxyproline. | 2002-10-04 |
|
| Promising therapies for cholesterol reduction. | 2002-09 |
|
| Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells. | 2002 |
|
| A novel strategy for the synthesis of neoglycoconjugates from deacylated deep rough lipopolysaccharides. | 2002 |
|
| p-Sulfonatocalix[6]arene is an effective coacervator of poly(allylamine hydrochloride). | 2001-11-07 |
|
| Colesevelam. | 2001 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:35:09 GMT 2025
by
admin
on
Mon Mar 31 18:35:09 GMT 2025
|
| Record UNII |
48G762T011
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7853
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY | |||
|
203-463-9
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY | |||
|
D000499
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY | |||
|
m1548
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID8024440
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY | |||
|
2065
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY | |||
|
ALLYLAMINE
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY | |||
|
107-11-9
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY | |||
|
7600
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY | |||
|
48G762T011
Created by
admin on Mon Mar 31 18:35:09 GMT 2025 , Edited by admin on Mon Mar 31 18:35:09 GMT 2025
|
PRIMARY |